Form 8-K - Current report:
SEC Accession No. 0001447028-24-000084
Filing Date
2024-10-11
Accepted
2024-10-11 16:07:36
Documents
14
Period of Report
2024-10-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K abus-20241011.htm   iXBRL 8-K 31811
2 EX-10.1 firstamendmenttomjsemploym.htm EX-10.1 48096
  Complete submission text file 0001447028-24-000084.txt   215204

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT abus-20241011.xsd EX-101.SCH 1898
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT abus-20241011_lab.xml EX-101.LAB 21629
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT abus-20241011_pre.xml EX-101.PRE 12506
17 EXTRACTED XBRL INSTANCE DOCUMENT abus-20241011_htm.xml XML 3027
Mailing Address 701 VETERANS CIRCLE WARMINSTER PA 18974
Business Address 701 VETERANS CIRCLE WARMINSTER PA 18974 604-419-3200
Arbutus Biopharma Corp (Filer) CIK: 0001447028 (see all company filings)

EIN.: 980597776 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34949 | Film No.: 241367642
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)